Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Bridgepoint Growth in conjunction with the entry of a partnership in DCHud Holding AB
Mandate

Vinge advises Bridgepoint Growth in conjunction with the entry of a partnership in DCHud Holding AB

November 10, 2020 Employment and Benefits Commercial Agreements M&A Corporate Crime & Compliance

Diagnostiskt Centrum Hud, the leading provider of medical dermatology services in Sweden, partnered with Bridgepoint Growth to further support the company’s expansion.

Today DCH operates six clinics across four Swedish cities and is the clear market leader in Sweden.

Vinge’s team primarily consisted of partner Daniel Rosvall together with associates Michaela Cronemyr, Elsie Nassar, Ellinor Wargenbrant and Olivia Belding (M&A) and Sara Strandberg (employment), Lisa Hörnqvist (commercial agreements) and Tove Lövgren Frisk (corporate, crime & compliance).

Related

Vinge advises Triton in connection with the divestment of Norstat to Nalka Invest

Vinge advises Triton Smaller Mid-Cap Fund I (“Triton”) in connection with the divestment of Norstat, a leading data collector for market research, to Nalka Invest.
April 12, 2024

Vinge advises Sobro in connection with investment in Clinton Marine Survey

 Clinton Marine Survey has chosen to broaden its ownership with Sobro as a new partner and majority shareholder. All existing owners remain as significant shareholders. Clinton Marine Survey offers high quality hydrographic and geological surveys for navigation, dredging operations, mapping, marine construction and more.
April 09, 2024

Vinge has advised Helix Kapital in connection with the fund formation of Helix Kapital Fund III

 Vinge has advised Helix Kapital in the establishment of Helix Kapital’s third fund, Helix Kapital Fund III. The fund closed successfully with commitments of approximately SEK 1.5 billion from an international investor base consisting of a number of leading financial institutions. The investor interest in the fund raising was very strong, and the fund was significantly oversubscribed.
April 05, 2024